RecruitingNCT06747039

Cannabis Extract in Fibromyalgia Syndrome - the SUNRISE Study

Studying NON RARE IN EUROPE: Fibromyalgia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Principal Investigator
Piercarlo Sarzi Puttini, Medical Doctor
IRCCS Ospedale Galeazzi Sant'Ambrogio
Enrollment
38 target
Eligibility
18 years · All sexes
Timeline
20242025

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06747039 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Fibromyalgia

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Fibromyalgia

← Back to all trials